Sign in

Private company

SUNWIN STEVIA INTERNATIONAL, INC.

Pharmaceutical preparations company1

In its 2022 annual report the company says: “We sell stevioside, a natural sweetener, and other pharmaceutical products. We have built an integrated company with the sourcing and production capabilities designed to meet the needs of our customers.”20 It is headquartered in Shandong, China.1

Last updated Oct 21, 2026.

Overview

$35.3MRevenue, fiscal 20222
-$2.9MNet income, fiscal 20222
  • IndustryPharmaceutical Preparations1
  • HeadquartersShandong, China1
  • Business address6 Shengwang Avenue,, Qufu, Shandong, F4 2731003
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

8.8%Gross margin2
-11.5%Operating margin2
-8.3%Net margin2
38.9%Revenue growth, 20222
-42.6%Return on equity2

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue91¢$32.2M
  • Research and development8¢$2.8M
  • Interest1¢$456.7K

Out of $35.3M in revenue.2 The company lost money this year.

Financial statements

Revenue4567892$35.3M in 2022+101% since 2015
0$10.0M$20.0M$30.0M$40.0M2015: $17.5M$17.5M20152016: $18.0M$18.0M2016+3%2017: $19.4M$19.4M2017+7%2018: $19.1M$19.1M2018−1%2019: $20.9M$20.9M2019+9%2020: $26.1M$26.1M2020+25%2021: $25.4M$25.4M2021−3%2022: $35.3M$35.3M2022+39%
Gross profit4567892$3.1M in 2022−7% since 2015
-$2.0M0$2.0M$4.0M$6.0M2015: $3.3M$3.3M20152016: $2.0M$2.0M2016−41%2017: $2.8M$2.8M2017+43%2018: $1.6M$1.6M2018−43%2019: $1.6M$1.6M2019−3%2020: $4.4M$4.4M2020+178%2021: -$1.1M-$1.1M20212022: $3.1M$3.1M2022
Operating income52-$4.1M in 2022−19% since 2016
-$6.0M-$4.0M-$2.0M02016: -$5.0M-$5.0M20162017: -$3.4M-$3.4M2017−33%2021: -$5.1M-$5.1M2021+50%2022: -$4.1M-$4.1M2022−20%
Net income4567892-$2.9M in 2022−36% since 2015
-$6.0M-$4.0M-$2.0M02015: -$4.5M-$4.5M20152016: -$4.8M-$4.8M2016+6%2017: -$3.9M-$3.9M2017−19%2018: -$4.7M-$4.7M2018+21%2019: -$4.9M-$4.9M2019+4%2020: -$1.4M-$1.4M2020−72%2021: -$3.2M-$3.2M2021+134%2022: -$2.9M-$2.9M2022−10%
Fiscal year20152016201720182019202020212022
Revenue$17.5M4$18.0M5$19.4M6$19.1M7$20.9M8$26.1M9$25.4M2$35.3M2
Cost of revenue$14.2M4$16.0M5$16.5M6$17.5M7$19.3M8$21.7M9$26.5M9$32.2M2
Gross profit$3.3M4$2.0M5$2.8M6$1.6M7$1.6M8$4.4M9-$1.1M2$3.1M2
Research and development$254.0K4$836.2K5$493.0K6$842.5K7$982.0K8$1.9M9$1.1M2$2.8M2
Operating expenses$7.2M2
Operating income-$5.0M5-$3.4M5-$5.1M2-$4.1M2
Interest-$79.1K4-$124.4K5-$257.6K6-$438.6K7$667.1K8$638.8K9$222.1K2$456.7K2
Income before tax-$4.6M2
Income tax$109.3K4$5.3K5$02$02
Net income-$4.5M4-$4.8M5-$3.9M6-$4.7M7-$4.9M8-$1.4M9-$3.2M2-$2.9M2
Earnings per share-$0.022-$0.012
Shares (weighted, basic)199.6M shares2
Shares (weighted, diluted)199.6M shares2

Compare SUNWIN STEVIA INTERNATIONAL, INC. with another company

What it owns

What SUNWIN STEVIA INTERNATIONAL, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Buildings and improvements$9.5M2 Apr 30, 2022$10.5M2 Apr 30, 2021−9.8%
Machinery and equipment$6.5M2 Apr 30, 2022$7.6M2 Apr 30, 2021−15.2%
Construction in progress$17.2K2 Apr 30, 2022$17.5K2 Apr 30, 2021−1.8%
Property and equipment, before depreciation$17.0M2 Apr 30, 2022$19.2M2 Apr 30, 2021−11.7%
Property and equipment, net$7.5M2 Apr 30, 2022$9.2M2 Apr 30, 2021−18.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.6M9 Apr 30, 2021$1.1M9 Apr 30, 2020+37.6%

Inventory

ItemLatestA year beforeChange
Inventory, total$5.6M2 Apr 30, 2022$12.9M2 Apr 30, 2021−57.0%
Raw materials$2.4M2 Apr 30, 2022$5.9M2 Apr 30, 2021−58.7%
Work in process$1.0M2 Apr 30, 2022$3.2M2 Apr 30, 2021−68.0%
Finished goods$2.1M2 Apr 30, 2022$3.9M2 Apr 30, 2021−45.2%

Leadership

Who has led SUNWIN STEVIA INTERNATIONAL, INC., and when. Pick a name to see everywhere that person has worked.

Chair

  1. Laiwang Zhang2009–2010

President

  1. Laiwang Zhang2009–2010

Chief financial officer

  1. Fanjun Wu2009–2010
2010201520202025
Board members and other officers (2)

Former names

  • SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.Dec 15, 2004 to May 14, 20123
  • NETWORK USA INCDec 15, 2000 to Sep 21, 20043

Timeline

  1. Jun 9, 20238-K Change of auditor17
  2. Mar 16, 20228-K Executive or director change18
  3. Oct 4, 20218-K Executive or director change19

Filings

16 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 3 major events, 8 other. The latest 16:

  1. Apr 23, 2025REVOKED EDGAR
  2. Aug 22, 2023NT 10-K EDGAR
  3. Jun 9, 20238-K SUNWIN STEVIA INTERNATIONAL, INC. - FORM 8-K SEC FILING EDGAR
  4. Mar 17, 2023NT 10-Q SUWN NT 10-Q EDGAR
  5. Jan 11, 202310-Q SUNWIN STEVIA INTERNATIONAL, INC. - FORM 10-Q SEC FILING EDGAR
  6. Dec 19, 2022NT 10-Q EDGAR
  7. Sep 19, 202210-Q SUNWIN STEVIA INTERNATIONAL, INC. - FORM 10-Q SEC FILING EDGAR
  8. Sep 14, 2022NT 10-Q EDGAR
  9. Aug 10, 202210-K SUNWIN STEVIA INTERNATIONAL, INC. - FORM 10-K SEC FILING EDGAR
  10. Jul 29, 2022NT 10-K EDGAR
  11. Apr 22, 202210-Q SUNWIN STEVIA INTERNATIONAL, INC. - FORM 10-Q EDGAR
  12. Mar 18, 2022NT 10-Q SUNWIN NT 10-Q EDGAR
  13. Mar 16, 20228-K SUNWIN STEVIA INTERNATIONAL, INC. - FORM 8-K SEC FILING EDGAR
  14. Dec 17, 202110-Q SUNWIN STEVIA INTERNATIONAL, INC. - FORM 10-Q SEC FILING EDGAR
  15. Dec 15, 2021NT 10-Q SUNWIN NT 10-Q EDGAR
  16. Oct 4, 20218-K SUNWIN STEVIA INTERNATIONAL, INC. - FORM 8-K SEC FILING EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How SUNWIN STEVIA INTERNATIONAL, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSUNWIN STEVIA INTERNATIONAL, INC.1
  • CIK0000806592
  • Employer ID (EIN)56-24169251
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Fiscal year endsApril 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address6 Shengwang Avenue,, Qufu, Shandong, F4 2731001
  • Phone(86) 537-44249991
  • Shares outstanding199,632,803 as of Jan 11, 202312
  • Public float$3.7M as of Oct 31, 20212
  • On EDGAR sinceJul 31, 20001
  • Filings250 in all: 8-K (53), 10-Q (44), 10QSB (24), NT 10-Q (18), 10-K (15), UPLOAD (15), NT 10-K (11), CORRESP (9)1
    All 28 form types

    10KSB (8), 3 (6), 8-K/A (6), 10-K/A (5), SB-2/A (5), 424B3 (4), S-8 (4), 4 (3), EFFECT (3), 10KSB/A (2), 10QSB/A (2), POS AM (2), REGDEX (2), SB-2 (2), SC 13D (2), 8-A12G (1), CT ORDER (1), NTN 10Q (1), REVOKED (1), SC 13G (1)

  • Latest filingsAnnual report (10-K) Aug 10, 2022
    Quarterly report (10-Q) Jan 11, 2023
    Latest 8-K (8-K) Jun 9, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20